Approved Prescription Drug Products
Title | Approved Prescription Drug Products PDF eBook |
Author | |
Publisher | |
Pages | 16 |
Release | 1980 |
Genre | Drugs |
ISBN |
Accompanied by supplements.
FDA Approved Animal Drug Products
Title | FDA Approved Animal Drug Products PDF eBook |
Author | |
Publisher | |
Pages | 144 |
Release | 1998 |
Genre | Veterinary drugs |
ISBN |
Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 31st Edition (2011)
Title | Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 31st Edition (2011) PDF eBook |
Author | Food and Drug Administration |
Publisher | DrugPatentWatch.com |
Pages | 1253 |
Release | 2011 |
Genre | Medical |
ISBN | 193489981X |
FDA Orange Book 31st Edition - 2011 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 29th Edition (2009)
Title | Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 29th Edition (2009) PDF eBook |
Author | Food and Drug Administration |
Publisher | DrugPatentWatch.com |
Pages | 1161 |
Release | 2009 |
Genre | Medical |
ISBN | 1934899798 |
FDA Orange Book 29th Edition - 2009 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Drug Safety
Title | Drug Safety PDF eBook |
Author | United States. General Accounting Office |
Publisher | |
Pages | 12 |
Release | 2001 |
Genre | Drugs |
ISBN |
Pain Management and the Opioid Epidemic
Title | Pain Management and the Opioid Epidemic PDF eBook |
Author | National Academies of Sciences, Engineering, and Medicine |
Publisher | National Academies Press |
Pages | 483 |
Release | 2017-09-28 |
Genre | Medical |
ISBN | 0309459575 |
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 28th Edition (2008)
Title | Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 28th Edition (2008) PDF eBook |
Author | Food and Drug Administration |
Publisher | DrugPatentWatch.com |
Pages | 1103 |
Release | 2008 |
Genre | Medical |
ISBN | 193489978X |
FDA Orange Book 28th Edition - 2008 (Approved Drug Products With Therapeutic Equivalence Evaluations)